Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 17 Mar 2023
Germany: Activation of bitter taste receptors opens lung pathways, making them potential targets for the treatment of chronic lung diseases...
Read Full News1.
Chemo-Free Quadruplet Shows Promise as DLBCL's First Therapy.
2.
Asandeutertinib Tops Osimertinib for NSCLC With Brain Mets
3.
Study finds 20 minutes of mindful breathing can rapidly reduce intensity of cancer pain
4.
GuCS: Genitourinary Cancers Symposium
5.
Hydroxyurea Shows Some Benefits in Milder Sickle Cell Disease
1.
All About Ferric Gluconate – The Best Source Of Iron For Anemia
2.
Senescence in Cancer Therapy: Mechanisms, Clinical Relevance, and Therapeutic Implications
3.
Unlocking the Potential of Etoposide: A Novel Approach to Cancer Treatment
4.
Artificial Intelligence in Oncology: Current Trends, Challenges and Future Outlook
5.
The Latest Research on Chronic Granulomatous Disease and Promising New Treatments
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
An In-Depth Look At The Signs And Symptoms Of Lymphoma
2.
What Therapy Would Yield the Best Outcomes In Patients with R/R B-cell ALL?
3.
Navigating the Complexities of Ph Negative ALL - Part IV
4.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part III
5.
Key Takeaways from The CROWN Trial For ALK + NSCLC Patients with CNS Diseases
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge